Hims & Hers Health, Inc.·4

Mar 13, 4:20 PM ET

Autor Deborah M. 4

4 · Hims & Hers Health, Inc. · Filed Mar 13, 2026

Research Summary

AI-generated summary of this filing

Updated

HIMS Director Deborah Autor Receives RSU Award

What Happened

  • Deborah M. Autor, Chief Policy Officer and a director at Hims & Hers Health, Inc. (HIMS), received an award of 526,711 restricted stock units (RSUs) on March 11, 2026. The Form 4 reports the grant as an award (transaction code A) with no cash paid (reported price $0.00). The RSUs are a contingent right to receive one share of Class A common stock per RSU upon vesting.

Key Details

  • Transaction date: 2026-03-11 (Form 4 filed 2026-03-13; timely filing).
  • Award: 526,711 RSUs; reported acquisition price: $0.00 (compensation grant).
  • Shares owned after transaction: 526,711 unvested RSUs (each convertible to one share upon vesting).
  • Vesting: Service-based over 4 years in substantially equal quarterly installments on March 15, June 15, September 15 and December 15; first vesting date is March 15, 2026 (see footnote).
  • Transaction code: A (award/grant). No 10b5-1 plan or tax-withholding details reported on the Form 4.

Context

  • RSUs are a form of compensation, not a purchase or sale of stock; their economic value depends on HIMS’s share price at vesting. These RSUs are unvested and will only convert to shares as they vest according to the schedule, potentially creating future taxable events and insider holdings when vesting occurs.

Insider Transaction Report

Form 4
Period: 2026-03-11
Autor Deborah M.
DirectorChief Policy Officer
Transactions
  • Award

    Restricted Stock Unit

    [F1][F2]
    2026-03-11+526,711526,711 total
    Class A Common Stock (526,711 underlying)
Footnotes (2)
  • [F1]The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
  • [F2]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date"), with the first such vesting date on March 15, 2026.
Signature
/s/ Kimberly Mather, Attorney-in-Fact for Deborah M Autor|2026-03-13

Documents

1 file
  • 4
    wk-form4_1773433244.xmlPrimary

    FORM 4